ea0029p368 | Clinical case reports - Pituitary/Adrenal | ICEECE2012
Bondanelli M.
, Malaspina A.
, Montis A.
, Ambrosio M.
, Lavezzi S.
, Basaglia N.
, Zatelli M.
, degli Uberti E.
Tolvaptan, an oral antagonist of the vasopressin V2 receptor, has been found to improve hyponatremia in patients with SIAD. We report the case of a 65-years-old male, who developed recurrent episodes of hyponatremia after severe traumatic brain injury, TBI, with polytrauma (CGS=8, decompressive craniectomy, spontaneous breathing by percutaneous tracheotomy). During hospitalization in intensive care unit he resumed alertness and received i.v. hypertonic saline infusion and oral...